CINECA IRIS Institutional Research Information System

LUCCHI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.359
AS - Asia 8.085
EU - Europa 6.280
SA - Sud America 1.361
AF - Africa 384
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 8
Totale 32.497
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.890
SG - Singapore 2.760
CN - Cina 2.210
IT - Italia 1.965
HK - Hong Kong 1.484
BR - Brasile 1.169
DE - Germania 1.100
SE - Svezia 901
BG - Bulgaria 545
VN - Vietnam 402
GB - Regno Unito 380
CA - Canada 358
TR - Turchia 310
RU - Federazione Russa 265
UA - Ucraina 254
FI - Finlandia 209
IN - India 206
KR - Corea 188
FR - Francia 161
AT - Austria 146
CI - Costa d'Avorio 142
BD - Bangladesh 93
JP - Giappone 76
CH - Svizzera 65
IQ - Iraq 59
SN - Senegal 57
AR - Argentina 54
MX - Messico 54
PL - Polonia 53
NL - Olanda 52
ZA - Sudafrica 44
VE - Venezuela 38
BE - Belgio 36
UZ - Uzbekistan 34
SA - Arabia Saudita 33
PK - Pakistan 31
ES - Italia 30
ID - Indonesia 28
CO - Colombia 25
JO - Giordania 25
MA - Marocco 25
EC - Ecuador 23
NG - Nigeria 23
EG - Egitto 22
IE - Irlanda 20
AE - Emirati Arabi Uniti 16
KE - Kenya 16
AU - Australia 15
PY - Paraguay 14
DZ - Algeria 13
IR - Iran 13
LT - Lituania 13
IL - Israele 12
NP - Nepal 11
PE - Perù 11
RO - Romania 11
TN - Tunisia 11
UY - Uruguay 11
AZ - Azerbaigian 10
CL - Cile 10
JM - Giamaica 10
OM - Oman 10
CZ - Repubblica Ceca 9
PH - Filippine 9
PT - Portogallo 8
DK - Danimarca 7
EU - Europa 7
KZ - Kazakistan 7
MY - Malesia 7
RS - Serbia 7
AL - Albania 6
AO - Angola 6
BB - Barbados 6
EE - Estonia 6
HN - Honduras 6
KG - Kirghizistan 6
AM - Armenia 5
BN - Brunei Darussalam 5
CR - Costa Rica 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
PA - Panama 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
MD - Moldavia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BJ - Benin 3
CG - Congo 3
GY - Guiana 3
HR - Croazia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LV - Lettonia 3
Totale 32.444
Salva come PNG Salva come JPEG
Città #
Ashburn 1.783
Woodbridge 1.558
Hong Kong 1.470
Fairfield 1.448
Singapore 1.442
Houston 1.117
Dallas 1.005
Chandler 958
Santa Clara 946
Ann Arbor 813
Seattle 622
Sofia 542
Cambridge 532
Shanghai 525
Wilmington 500
Beijing 480
New York 399
Milan 321
Boardman 314
Ottawa 275
Los Angeles 268
Hefei 242
Princeton 238
Jacksonville 232
Pisa 231
Lawrence 221
Florence 215
Medford 195
Seoul 180
Serra 172
Izmir 170
Nanjing 159
Des Moines 147
Abidjan 142
Munich 126
Vicopisano 126
Frankfurt am Main 122
Vienna 117
São Paulo 114
Buffalo 99
Redondo Beach 99
Istanbul 98
San Diego 91
Dearborn 85
London 69
Bremen 67
Boulder 63
Ho Chi Minh City 63
Nanchang 62
Tokyo 62
Bern 59
Dong Ket 58
The Dalles 58
Dakar 57
Columbus 56
Ogden 56
Hanoi 54
Council Bluffs 52
Rome 50
Turku 50
Kunming 47
San Jose 47
Pune 45
Paris 44
Warsaw 40
Jüchen 38
Chicago 37
Lancaster 36
Rio de Janeiro 36
Falls Church 35
Nuremberg 35
Brussels 34
Tashkent 32
Phoenix 29
Redwood City 29
Tianjin 29
Shenyang 28
Fuzhou 27
Lucca 27
Belo Horizonte 26
Montreal 26
Cascina 25
Baghdad 24
Dhaka 24
Jiaxing 24
Porto Alegre 24
Toronto 24
Hebei 23
Turin 23
Johannesburg 22
Amman 21
Boston 21
Changsha 21
Guangzhou 21
Lagos 21
Pontedera 21
Atlanta 20
Düsseldorf 20
Norwalk 20
Chennai 19
Totale 23.020
Salva come PNG Salva come JPEG
Nome #
null 346
Expression status of candidate genes in mesothelioma tissues and cell lines 320
La densità microvascolare (DMV) come marker prognostico e predittivo nelle neoplasie maligne dell'albero bronchiale in fase avanzata. 285
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 255
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience 229
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis 224
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma 209
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 208
Percutaneous radiofrequency ablation (pRTA) of pulmonary tumors 204
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 201
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 199
210P: Digital gene expression profiling to separate malignant pleural mesothelioma from benign reactive mesothelial hyperplasia 195
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 192
Surgical treatment of pleural recurrence from thymoma 188
Second primary lung cancer and relapse: treatment and follow-up. 183
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 183
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis. 183
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 182
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 182
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma 180
TERMOABLAZIONE DI NEOPLASIE POLMONARI MALIGNE: QUALI PROSPETTIVE 179
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 176
Four thymus-related syndromes in a case of invasive thymoma 176
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 175
Screen-detected multiple primary lung cancers in the ITALUNG trial 175
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas 172
Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. 170
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma 170
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 170
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 169
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 169
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 169
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial 169
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 167
2ND PRIMARY LUNG-CANCER AND RELAPSE - TREATMENT AND FOLLOW-UP 165
A gene-expression-based test can outperform bap1 and p16 analyses in the differential diagnosis of pleural mesothelial proliferations. 165
Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer. 163
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 163
Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study 163
Surgical treatment of NSCLC in octuagenarians. 162
KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung 162
Neoangiogenesis as prognostic indicator of survival in lung cancer. 161
A strategy for thoracoscopic resection of small pulmonary nodules 161
The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis 160
Accumulation of gene protein product P53 correlates with high microvessel count in non small cell lung carcinomas 159
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 158
ALK rearrangement in a large series of consecutive non-small cell lung cancers: Comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment 158
[18F]FDG-PET/CT patterns of bone metastases in lung cancer 157
Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development 157
Chest wall resection for mesothelioma recurrence after surgery 157
Favourable survival outcome in patients with SCLC treated by sequential intensive chemotherapy and high dose chest irradiation 152
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 151
The multimodality treatment of thymic carcinoma 150
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 150
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations 150
Polymer self-locking clips for vascular control during minimally invasive pulmonary lobectomies 148
Surgical treatment of non-small cell lung cancer in octogenarians 147
Radio-guided thoracoscopic surgery (RGTS) of small pulmonary nodules. 147
Reply to heyman and van schil 146
Acute major airway injuries: clinical features and management 146
Evaluation of the Incidence and Potential Mechanisms of Tracheal Complications in Patients With COVID-19 146
Comparative analysis of genetic variants in pleural fluids and solid tissue biopsies of pleural mesothelioma patients: Implications for molecular heterogeneity assessment 145
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 145
Pleural recurrence of thymoma: Surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy 145
Robotic lobectomy for lung cancer: Evolution in technique and technology 145
Gene-specific methylation analysis in thymomas of patients with myasthenia gravis 145
WWOX expression in different histologic types and subtypes of non-small cell lung cancer 144
Ten-year experience of mediastinal robotic surgery in a single referral centre 144
Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment 144
Massive pneumoencephalus of late onset after an en-bloc resection for lung cancer 143
Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. 143
New Keywords in the Treatment of Malignant Pleural Mesothelioma 143
Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung 143
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 143
Imaging of malignant pleural mesothelioma: It is possible a screening or early diagnosis program? - A systematic review about the use of screening programs in a population of asbestos exposed workers 142
N2 lung cancer is not all the same: an analysis of different prognostic groups 142
null 141
Surgical treatment of recurrent thymomas 140
Investigation of GHSR methylation levels in thymomas from patients with Myasthenia Gravis 139
null 138
Robotic extended thymectomy for early-stage thymomas 138
MIB1 labelling does not affect metastasis and overall survival in non small cell lung carcinomas 137
Gastropleural fistula as complication of post-pneumonectomy empyema 137
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. 137
Endoscopic thymectomy: A neurologist's perspective 136
Investigation of MLH1, MGMT, CDKN2A, and RASSF1A Gene Methylation in Thymomas From Patients With Myasthenia Gravis 136
Video robotic lobectomy 135
Gamma-probe guided thoracoscopic surgery of small pulmonary nodules 135
Transcollation® technique in the thoracoscopic treatment of primary spontaneous pneumothorax 135
Percutaneous radiofrequency ablation of primary NSCLC 134
Nerve-Sparing Surgery in Advanced Stage Thymomas 134
Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results 134
Thymic carcinoma: a report of 13 cases 133
Alterazioni del gene Fas (APO-1/CD95) nei carcinomi polmonari non a piccole cellule (NSCLC). Correlazioni con le alterazioni del gene P53. 132
Percutaneous radiofrequency ablation of primary NSCLC 132
Is left upper lobectomy always worthwhile for early stage lung cancer? A comparison between left upper lobectomy, trisegmentectomy, and lingulectomy 132
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 131
CERENKOV LUMINESCENCE IMAGING IN PULMONARY AND HEPATIC METASTASECTOMY 131
Osteopontin expression and prognostic significance in non-small cell lung cancer 129
IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment 129
Totale 16.349
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021954 0 0 0 0 0 0 101 161 172 125 115 280
2021/20222.660 23 170 97 130 487 371 139 124 165 149 132 673
2022/20233.053 369 375 229 289 307 413 42 219 549 11 221 29
2023/20242.234 199 193 236 269 306 394 120 79 41 40 117 240
2024/20258.504 153 301 74 464 821 758 674 420 916 1.039 956 1.928
2025/20265.599 600 1.152 1.157 839 968 876 7 0 0 0 0 0
Totale 32.967